Abstract:Three Ag(I) bis (phenanthroline-oxazine) complexes with varying lipophilicity were synthesised and characterised. The solution stoichiometry of 1:2 Ag(I):ligand was determined for each complex by the continuous variation Job's plot method using NMR spectroscopy. NMR studies were also carried out to investigate the fluxional behaviour of the Ag(I) complexes in solution. The biological activity of the silver(I) complexes and the corresponding ligands towards a clinical strain of Candida albicans MEN was studied using broth microdilution assays. Testing showed the choice of media and the duration of incubation were key determinants of the inhibitory behaviour towards Candida albicans, however, the difference between freshly prepared and pre-prepared solutions was insignificant in minimal media. The activity of the metal-free ligands correlated with the length of the alkyl chain. In minimal media, the methyl ester phenanthroline-oxazine ligand was effective only at 60 μM, limiting growth to 67% of the control, while a 60 μM dose of the propyl ester analogue limited fungal growth at < 20% of the control. MIC 50 and MIC 80 values for the propyl and hexyl ester analogues were calculated to be 45 and 59 μM (propyl), and 18 and 45 μM (hexyl). Moreover, in a study of activity as a function of time it was observed that the hexyl ester ligand maintained its activity for longer than the methyl and propyl analogues; after 48 h a 60 μM dose held fungal growth at 24% of that of the control. Complexation to Ag(I) was much more effective in enhancing biological activity of the ligands than was increasing the ester chain length. Significantly no difference in activity between the three silver(I) complexes was observed under the experimental conditions. All three complexes were substantially more active than their parent ligands against Candida albicans and AgClO 4 and the three silver(I) bis (phen-oxazine) complexes have MIC 80 values of < 15 μM. The ability of the silver(I) complexes to hold fungal growth at about 20% of the control even after 48 h incubation at low dosages (15 μM) showcases their superiority over the simple silver(I) perchlorate salt, which ceased to be effective at dosages below 60 μM at the extended time point.

Synthesis, crystal structure and in vitro antifungal activity of two-dimensional silver(I)-voriconazole coordination complexes

Synthesis, crystal structures and in vitro anti-fungal activities of two silver(I) coordination polymers with fluconazole

Silver(I) complexes with voriconazole as promising anti- Candida agents

Silver(I) complexes containing antifungal azoles: Significant improvement of the anti-Candida potential of the azole drug after its coordination to the silver(I) ion

Synthesis, Structural Characterization, Hirshfeld Surface, DFT Calculation and Antifungal Activity of Novel Quinoline Carbonothioate Compounds

Synthesis, crystal structure and in vitro antibacterial activity of two novel silver(I) complexes

Investigation into the structures and physicochemical properties of multi-component crystals of voriconazole

Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

Design, synthesis and in vitro biological studies of novel triazoles with potent and broad-spectrum antifungal activity

Synthesis, crystal structure, spectroscopic characterization and anti-fungal activity of Ethyl 2-Oxo-2H-chromene-3-carboxylateDerivatives

Synthesis, crystal structure, density functional theory calculations, and antimicrobial activity of silver(I) complex derived from 2‐aminobenzothiazole ligand

Synthesis, characterisation, and solution behaviour of Ag(I) bis(phenanthroline-oxazine) complexes and the evaluation of their biological activity against the pathogenic yeast Candida albicans

Synthesis, Molecular Docking, and Biological Evaluation of Novel Triazole Derivatives as Antifungal Agents

Synthesis, antifungal activity and molecular docking of (E) -3- ( ( (1, 3, 4-thiadiazol-2-yl) amino) methylene) -thiochroman-4-ones

Discovery of highly potent triazole derivatives with broad-spectrum antifungal activity based on Iodiconazole

Synthesis and Antifungal Activities of 1-(1 H-1,2,4- Triazol-1-yl)-2-(3,3-dimethyl)-3-[(4-substituted)-piperazin-1-yl]-2-propanols

Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains.

Design, Synthesis and Molecular Docking Studies of Novel Triazole Antifungal Compounds

Synthesis and Antifungal Activity of 1-(1H-1,2,4-triazol-1-yl)-2-(3,3-dimethyl)-3-[(4-substituted)-piperazin-1-yl]-2-propanols

Synthesis of kanamycin-azole hybrids and investigation of their antifungal activities

Design, synthesis, and evaluation of novel tetrazoles featuring isoxazole moiety as highly selective antifungal agents